Association between NMR metabolomic signatures of healthy lifestyle and incident coronary artery disease
- PMID: 36317303
- DOI: 10.1093/eurjpc/zwac252
Association between NMR metabolomic signatures of healthy lifestyle and incident coronary artery disease
Abstract
Aims: To identify metabolites associated with a healthy lifestyle and explore the possible mechanisms of lifestyle in coronary artery disease (CAD).
Methods and results: The nuclear magnetic resonance metabolomics platform was applied to perform metabolomic profiling of baseline plasma samples from a randomly selected subset of 121 733 UK Biobank participants. Cox proportional hazards models with covariate adjustments were used to investigate the associations between validated lifestyle-associated metabolites and incident CAD and to estimate the accuracy of the inclusion of metabolites to predict CAD compared with traditional prediction models. The discriminatory ability of each model was evaluated using Harrell's C statistic, integrated discrimination improvement (IDI), and continuous net reclassification improvement (NRI) indexes. During a median of 8.6 years of follow-up, 5513 incident CAD cases were documented. Among the 111 lifestyle-associated metabolites, 65 were significantly associated with incident CAD after multivariate adjustment (Bonferroni P < 3.11 × 10-04). The addition of these metabolites to classic risk prediction models [Framingham Risk Score (FRS) using lipids; FRS using body mass index] improved CAD prediction accuracy as assessed by the C statistic (increasing to 0.739 [95% CI, 0.731-0.747] and 0.752 [95% CI, 0.746-0.758]), respectively; continuous NRI (0.274 [0.227-0.325] and 0.266 [0.223-0.317]) and IDI (0.003 [0.002-0.004] and 0.003 [0.002-0.004]).
Conclusion: Healthy lifestyle-associated metabolites are associated with the incidence of CAD and may help improve the prediction of CAD risk. The use of metabolite information combined with the FRS model warrants further investigation before clinical implementation.
Keywords: Coronary artery disease; Framingham risk score; Model discrimination; NMR metabolomics; UK Biobank cohort study.
© The Author(s) 2022. Published by Oxford University Press on behalf of the European Society of Cardiology. All rights reserved. For permissions, please email: journals.permissions@oup.com.
Conflict of interest statement
Conflict of interest: The authors declare that they have no competing interests.
Comment in
-
Can conventional cardiovascular risk prediction models be improved by nuclear magnetic resonance (NMR) metabolomic signatures?Eur J Prev Cardiol. 2023 Feb 14;30(3):241-242. doi: 10.1093/eurjpc/zwac306. Eur J Prev Cardiol. 2023. PMID: 36545900 No abstract available.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
